The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemia
The effect of the serotherapy regimen used and the marrow cell dose received on rejection, graft-versus-host disease and outcome following unrelated donor bone marrow transplantation for leukaemia
J. Byrne,J. Byrne,8 Authors,N. Russell
2000 · DOI: 10.1038/sj.bmt.1702165
Bone Marrow Transplantation · 67 Citations
TLDR
It is concluded that pre-transplant serotherapy alone is highly effective at preventing acute GVHD following UD BMT and that additional post-trans transplant serotherapy does not confer any benefit.